The following tables show that the level of infection, cell type and mycoplasma strains may influence specific results. We encourage researchers to use this data as a helpful guide to indicate the effective Mycoplasma Removal Agent concentration needed with their specific cell line and mycoplasma strain.
Mycoplasma Removal Effect – Spontaneous Infection |
|||||
|---|---|---|---|---|---|
| Concentration of MRA | (ug/ml) | Days* | |||
| 0 | 7 | 14 | 21 | ||
| Human-derived cell-A | 0.39 | + | - | - | - |
| 0.2 | + | - | - | - | |
| 0.1 | + | - | + | + | |
| 0 | + | + | + | + | |
| Human-derived cell-B | 0.78 | + | - | - | - |
| 0.39 | + | - | - | - | |
| 0.2 | + | - | - | - | |
| 0.1 | + | + | + | + | |
| 0 | + | + | + | + | |
(+) = Mycoplasma positive, (-) = Mycoplasma negative, (Days*) = Mycoplasma status at stage of culture (days).
Comparisons with other antibiotics on the market such as Tiamulin and Minocycline shows that Mycoplasma Removal Agent is comparable for its minimum inhibitory concentration (MIC), with MICs from as low as 0.1 µg/ml for all the tested bacteria (see Table 2). This shows that if you are looking to inhibit the growth of Mycobacteria within your cultures, you can reliably use Mycoplasma Removal Agent because it is just as effective as other antibiotics which target mycobacteria.
Where Mycoplasma Removal Agent out performs the other tested antibiotics is in its low Minimum Microbicidal Concentration (MMC) which shows consistently low concentrations required for microbicidal effect (see Table 2). This enables you to confidently kill and remove mycoplasma from cultures at low concentrations of antibiotic. This reduces the chance that the antibiotic will have any inhibitory effects upon other cells in your culture.
Efficacy Comparison of MRA and Pharmaceuticals on the Market |
||||||
|---|---|---|---|---|---|---|
| MRA | Tiamulin | Minocycline | ||||
| MIC* | MMC** | MIC | MMC | MIC | MMC | |
| Mycoplasma orale CH-19299 | 0.05 | 0.1 | 0.0031 | 3.13 | 0.05 | 25.0 |
|
Mycoplasma arginini G-230
|
0.1 | 0.2 | 0.0063 | 12.5 | 0.2 | (>)100 |
| Mycoplasma hyorhinis BST-7 | 0.05 | 0.1 | 0.0031 | 0.39 | 0.0031 | 0.39 |
| Acholeplasma laidlawii PG-8> | 0.0125 | 0.025 | 0.05 | (>)100 | 0.05 | (>)100 |
| MMC/MIC | 2 | 128 - (>) 2048 | 512 - (>) 2048 | |||
*MIC = Minimum inhibitory concentration (µg/ml), **MMC = Minimum microbicidal concentration (µg/ml)
You'll receive regular communications featuring free lab resources such as application guides, posters, mini-reviews, protocols, practical tips, webinar invitations, special offers, and updates on new research tools and products.
You'll also get our specialist newsletters—including Fab Fragments, Flow. Sorted., and RiVETing—along with news on the latest antibody innovations, such as TrailBlazer™ Antibodies and StarBright™ Dyes.
During sign-up, you can choose your areas of interest so you only receive content relevant to your research, and you can unsubscribe at any time.